April 23rd Gapping Up / Gapping Down

Gapping Down

Gapping down on weak earnings/guidance: AMCC -15.3%, SIFY -6.9%… Other news: AGIX -17.8% (ends collaboration with AZN for AGI-1067), EPCT -7.6% (profit taking following Friday’s surge), JSDA -4.5% (downgraded at Stifel), AZN -3.5% (to acquire MEDI), NYX -3.6% (downgraded to Sell at Goldman).

Gapping Up

Gapping up on strong earnings/guidance: HAS +9.2%, HSC +3.9%… M&A: GCO +39% (co’s Board of Directors rejected FL’s unsolicited $46.00/share buyout offer), MEDI +18.0% (to be bought by AZN for $15.6 bln)… Other: AVNR +14.8% (ends research collaboration with AZN, issues guidance in separate press release), PCYC +13.4% (announces FDA filing of NDA for Xcytrin Injection to treat lung cancer brain metastases), MVIS +8.4% (announced contract with transportation sector systems integrator), SCON +7.2% (confirms $4.7 mln U.S. Air Force contract), FTEK +7.7% (positive mention by Cramer).